Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase

Journal of Medicinal Chemistry

Volumn 51, Issue 22, 2008, Pages 7057-7060

  Minkkilä, Anna ^a   Saario, Susanna M ^a   Käsnänen, Heikki ^a   Leppänen, Jukka ^a   Poso, Antti ^a   Nevalainen, Tapio ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLGLYCEROL LIPASE; BENZENEBORONIC ACID; BORONIC ACID DERIVATIVE; FATTY ACID AMIDASE;

ARTICLE; DRUG ACTIVITY; DRUG INHIBITION; IC 50;

AMIDOHYDROLASES; BORONIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DISCOVERY; ENZYME INHIBITORS; MOLECULAR STRUCTURE; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 56749107455     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm801051t     Document Type: Article

References (43)

1. Cravatt, B. F.; Giang, D. K.; Mayfield, S. P.; Boger, D. L.; Lerner, R. A.; Gilula, N. B. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 1996, 384, 83-87.
2. Giang, D. K.; Cravatt, B. F. Molecular characterization of human and mouse fatty ccid amide hydrolases. Proc. Natl. Acad. Sci. U.S.A. 1997, 4, 2238-2242.
3. Devane, W. A.; Hanus, L.; Breuer, A.; Pertwee, R. G.; Stevenson, L. A.; Griffin, G.; Gibson, D.; Mandelbaum, A.; Etinger, A.; Mechoulam, R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258, 1946-1949.
4. Mechoulam, R.; Ben-Shabat, S.; Hanus, L.; Ligumsky, M.; Kaminski, N. E.; Schatz, A. R.; Gobher, A.; Almog, S.; Martin, B. R.; Compton, D. R.; Pertwee, R. G.; Griffin, G.; Bayewitch, M.; Barg, J.; Vogel, Z. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 1995, 50, 83-90.
5. Sugiura, T.; Kondo, S.; Sukawaga, A.; Nakane, S.; Shinoda, A; Itoh, K.; Yamasita, A.; Waku, K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 1995, 215, 89-97.
6. Devane, W. A., 3rd; Johnson, M. R.; Melvin, L. S.; Howlett, A. C. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 1988, 34, 605-613.
7. Matsuda, L. A.; Lolait, S. J.; Brownstein, M. J.; Young, A. C.; Bonner, T. I. Structure of cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346, 561-564.
8. Munro, S.; Thomas, K. L.; Abu-Shaar, M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365, 61-65.
9. Stella, N.; Schweitzer, P.; Piomelli, D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 1997, 388, 773-778.
10. Sugiura, T.; Kodaka, T.; Nakane, S.; Miyahita, T.; Kondo, S.; Suhara, Y.; Takayama, H.; Waku, K.; Seki, C.; Baba, N.; Ishima, Y. Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds. J. Biol. Chem. 1999, 274, 2794-2801.
11. Lambert, D. M.; Fowler, C. J. The endocannabinoid system: drag targets, lead compounds, and potential therapeutic applications. J. Med. Chem. 2005, 48, 5059-5087.
12. Dinh, T. P.; Carpenter, D.; Leslie, F. M.; Freund, T. F.; Katona, I.; Sensi, S. L.; Kathuria, S.; Piomelli, D. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 10819-10824.
13. Blankman, J. L.; Simon, G. M.; Cravatt, B. F. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem. Biol. 2007, 14, 1309-1311.
14. Kathuria, S.; Gaetani, S.; Fegley, D.; Valino, F.; Duranti, A.; Tontini, A.; Mor, M.; Tarzia, G.; La Rana, G.; Calignano, A.; Giustino, A.; Tattoli, M.; Palmery, M.; Cuomo, V.; Piomelli, D. Modulation of anxiety through blockade of anandamide hydrolysis. Nat. Med. 2003, 9, 76-81.
15. Jaymanne, A.; Greenwood, R.; Mitchell, V. A.; Asian, S.; Piomelli, D.; Vaughan, C. W. Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models. Br. J. Pharmacol. 2006, 147, 281-288.
16. Deutch, D. G.; Lin, S.; Hill, W. A.; Morse, K. L.; Salehani, D.; Arreaza, G.; Omeir, R. L.; Makriyannis, A. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid Receptor. Biochem. Biophys. Res. Commun. 1997, 231, 217-221.
17. Segall, Y.; Quistad, G. B.; Nomura, D. K.; Casida, J. E. Arachidonylsulfonyl derivatives as cannabinoid CB1 receptor and fatty Acid amide hydrolase inhibitors. Bioorg. Med. Chem. Lett. 2003, 13, 3301-3303.
18. Deutch, D. G.; Omeir, R.; Arreaza, G.; Salehani, D.; Prestwich, G. D.; Huang, Z.; Howlett, A. Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase. Biochem. Pharmacol. 1997, 53, 255-260.
19. Koutek, B.; Prestwich, G. D.; Howlett, A. C.; Chin, S. A.; Salehani, D.; Akhavan, N.; Deutch, D. G. Inhibitors of arachidonoyl ethanolamide hydrolysis. J. Biol. Chem. 1994, 269, 22937-22940.
20. De Petrocellis, L.; Melck, D.; Ueda, N.; Maurelli, S.; Kurahashi, Y.; Yamamoto, S.; Marino, G.; Di Marzo, V. Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase. Biochem. Biophys. Res. Commun. 1997, 231, 82-88.
21. Boger, D. L.; Sato, H.; Lerner, A. E.; Hedrick, M. P.; Fecik, R. A.; Miyauchi, H.; Wilkie, G. D.; Austin, B. J.; Patricelli, M. P.; Cravatt, B. F. Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 5044-5049.
22. Lichtman, A. H.; Leung, D.; Shelton, C.; Saghatelian, A.; Hardouin, C.; Boger, D. L.; Cravatt, B. F. Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecented combination of potency and selectivity. J. Pharmacol. Exp. Ther. 2004, 311, 441-448.
23. Myllymäki, M. J.; Saario, S. M.; Kataja, A.; Castillo-Melendez, J. A.; Nevalainen, T.; Juvonen, R. O.; Järvinen, T.; Koskinen, A. M. P. Design, synthesis, and in vitro evaluation of carbamate derivatives of 2-benzoxazolyl- and 2-benzothiazolyl-(3-hydroxyphenyl)-methanones as novel fatty acid amide hydrolase inhibitors. J. Med. Chem. 2007, 50, 4236-4242.
24. Sit, S.-Y.; Xie, K. WO Patent 087569, 2002.
25. Ahn, K.; Johnson, D. S.; Fitzgerald, L. R.; Liimatta, M.; Arendse, A.; Stevenson, T.; Lund, E. T.; Nugent, R. A.; Nomanbhoy, T. K.; Alexander, J. P.; Cravatt, B. F. Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity. Biochemistry 2007, 46, 13019-13030.
26. Chang, L.; Luo, L.; Palmer, J. A.; Sutton, S.; Wilson, S. J.; Barbier, A. J.; Breitenbucher, J. G.; Chaplan, S. R.; Webb, M. Inhibition of fatty acid amide hydrolase produces analgesia by multible mechanisms. Br. J. Pharmacol. 2006, 148, 102-113.
27. Holt, S.; Comelli, F.; Costa, B.; Fowler, C. J. Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors. Br. J. Pharmacol. 2005, 146, 467-476.
28. Russo, R.; Loverne, J.; La Rana, G.; Compton, T. R.; Parrot, J.; Duranti, A.; Tontini, A.; Mor, M.; Tarzia, G.; Calignano, A.; Piomelli, D. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3′-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice. J. Pharmacol. Exp. Ther. 2007, 322, 236-242.
29. Jhaveri, M. D.; Richardson, D.; Kendall, D. A.; Barret, D. A.; Chapman, V. Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain. J. Neurosci. 2006, 26, 13318-13327.
30. Gobbi, G.; Bambico, F. R.; Mangieri, R.; Bortolato, M.; Campolongo, P.; Solinas, M.; Cassano, T.; Morgese, M. G.; Debonnel, G.; Duranti, A.; Tontini, A.; Tarzia, G.; Mor, M.; Trezza, V.; Goldberg, S. R.; Cuomo, V.; Piomelli, D. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 18620-18625.
31. Saario, S. M.; Savinainen, J. R.; Laitinen, J. T.; Järvinen, T.; Niemi, R. Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. Biochem. Pharmacol. 2004, 67, 1381-1387.
32. Tornqvist, H.; Belfrage, P. Purification and some properties of a monoglycerol-hydrolyzing enzyme of rat adipose tissue. J. Biol. Chem. 1976, 251, 813-819.
33. Saario, S. M.; Salo, O. M. H.; Nevalainen, T.; Poso, A.; Laitinen, J. T.; Järvinen, T.; Niemi, R. Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes. Chem. Biol. 2005, 12, 649-659.
34. Yang, W.; Gao, X.; Wang, B. Boronic acid compounds as potential pharmaceutical agents. Med. Res. Rev. 2003, 23, 346-368.
35. Adams, J.; Behnke, M. L.; Castro, A. C.; Evans, C. A.; Crenier, L.; Grogan, M. J.; Liu, T.; Snyder, D. A.; Tibbits, T. T. WO Patent Appl. 063300, 2008.
36. Patricelli, M. P.; Cravatt, B. F. Fatty acid hydrolase competitively degrades bioactive amides and esters through a nonconventinal catalytic mechanism. Biochemistry 1999, 38, 14125-14130.
37. Patricelli, M. P.; Lovato, M. A.; Cravatt, B. F. Chemical and mutagenic investigations of fatty acid amide hydrolase: evidence for a family of serine hydrolases with distinct catalytic properties. Biochemistry 1999, 38, 9804-9812.
38. Bracey, M. H.; Hanson, M. A.; Masuda, K. R.; Stevens, R. C.; Cravatt, B. F. Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling. Science 2002, 298, 1793-1796.
39. Saario, S. M.; Poso, A.; Juvonen, R. O.; Järvinen, T.; SaIo, O. M. H. Fatty acid amide inhibitors from virtual screening of the endocannabinoid system. J. Med. Chem. 2006, 49, 4650-4656.
40. Hall, D. G. Structure, Properties, and Preparation of Boronic Acid Derivatives. Overview of Their Reactions and Applications. In Boronic Acids, 1st ed.; Hall, D. G., Eds.; Wiley-VCH: Weinheim, Germany, 1995; pp 1-99.
41. Clark, A. M.; Labute, P.; Santavy, M. 2D structure depiction. J. Chem. Inf. Model. 2006, 46, 1107-1123.
42. Tubert-Brohman, I.; Acevedo, O.; Jorgensen, W. L. Elucidation of hydrolysis mechanisms for fatty acid amide hydrolase and its Lys142Ala variant via QM/MM simulations. J. Am. Chem. Soc. 2006, 128, 16904-16913.
43. Lodola, A.; Mor, M.; Rivara, S.; Christov, C.; Tarzia, G.; Piomelli, D.; Mulholland, A. J. Identification of productive inhibitor binding orientation in fatty acid amide hydrolase (FAAH) by QM/MM mechanistic modelling. Chem. Commun. 2008, 2, 214-216.